BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shiffman ML. Universal screening for chronic hepatitis C virus. Liver Int 2016;36:62-6. [DOI: 10.1111/liv.13012] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Trucchi C, Orsi A, Alicino C, Sticchi L, Icardi G, Ansaldi F. State of the Art, Unresolved Issues, and Future Research Directions in the Fight against Hepatitis C Virus: Perspectives for Screening, Diagnostics of Resistances, and Immunization. J Immunol Res 2016;2016:1412840. [PMID: 27843956 DOI: 10.1155/2016/1412840] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
2 Burrell CN, Sharon MJ, Davis SM, Wojcik EM, Martin IBK. Implementation of a Collaborative HIV and Hepatitis C Screening Program in Appalachian Urgent Care Settings. West J Emerg Med 2018;19:1057-64. [PMID: 30429942 DOI: 10.5811/westjem.2018.9.39512] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wigneswaran J, Van Wyck D, Pegues D, Gholam P, Nissenson AR. Hepatitis C virus infection in patients with end-stage renal disease: Hepatitis C in renal patients. Hemodialysis International 2018;22:297-307. [DOI: 10.1111/hdi.12672] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
4 Hossain N, Puchakayala B, Kanwar P, Verma S, Abraham G, Ivanov Z, Niaz MO, Mohanty SR. Risk Factor Analysis Between Newly Screened and Established Hepatitis C in GI and Hepatology Clinics. Dig Dis Sci 2017;62:3193-9. [PMID: 28913613 DOI: 10.1007/s10620-017-4754-0] [Reference Citation Analysis]
5 Spaulding AC, Miller LS. Apportioning blame in the North American hepatitis C virus epidemic. Lancet Infect Dis 2016;16:626-7. [PMID: 27039039 DOI: 10.1016/S1473-3099(16)30002-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
6 Angelidakis G, Hwang JP, Dandachi D, Economides MP, Hosry J, Granwehr BP, Torres HA. Universal screening for hepatitis C: A needed approach in patients with haematologic malignancies. J Viral Hepat 2018;25:1102-4. [PMID: 29660201 DOI: 10.1111/jvh.12913] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
7 Shiffman ML, Gunn NT. Impact of hepatitis C virus therapy on metabolism and public health. Liver Int 2017;37 Suppl 1:13-8. [PMID: 28052632 DOI: 10.1111/liv.13282] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
8 McGrew C, MacCallum DS, Narducci D, Nuti R, Calabrese L, Dimeff R, Paul S, Poddar SK, Rao A, McKeag D. AMSSM Position Statement Update: Blood-Borne Pathogens in the Context of Sports Participation. Clin J Sport Med 2020;30:283-90. [PMID: 30893122 DOI: 10.1097/JSM.0000000000000738] [Reference Citation Analysis]
9 Jhaveri R. Screening for Hepatitis C Virus: How Universal Is Universal? Clin Ther 2020;42:1434-41. [PMID: 32712026 DOI: 10.1016/j.clinthera.2020.06.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Tien A, Sahota A, Yang SJ, Balbuena R, Chang M, Lim C, Fong TL. Prevalence and Characteristics of Chronic Hepatitis C Among Asian Americans Are Distinct From Other Ethnic Groups. J Clin Gastroenterol 2021;55:884-90. [PMID: 33074947 DOI: 10.1097/MCG.0000000000001447] [Reference Citation Analysis]
11 Calvaruso V, Petta S, Craxì A. Is global elimination of HCV realistic? Liver Int 2018;38 Suppl 1:40-6. [PMID: 29427499 DOI: 10.1111/liv.13668] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
12 Jose R, Kahal D, Testa K, Goldstein ND; MBI4. A Qualitative Study of Implementing Universal Hepatitis C Screening Among Adults at an Urban Community-Based Health Provider in Delaware. Dela J Public Health 2021;7:16-23. [PMID: 34467206 DOI: 10.32481/djph.2021.07.006] [Reference Citation Analysis]
13 McGrew C, MacCallum DS, Narducci D, Nuti R, Calabrese L, Dimeff RJ, Paul S, Poddar S, Rao A, McKeag D. AMSSM position statement update: blood-borne pathogens in the context of sports participation. Br J Sports Med 2020;54:200-7. [PMID: 30890535 DOI: 10.1136/bjsports-2019-100650] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
14 Cooke GS, Andrieux-Meyer I, Applegate TL, Atun R, Burry JR, Cheinquer H, Dusheiko G, Feld JJ, Gore C, Griswold MG, Hamid S, Hellard ME, Hou J, Howell J, Jia J, Kravchenko N, Lazarus JV, Lemoine M, Lesi OA, Maistat L, McMahon BJ, Razavi H, Roberts T, Simmons B, Sonderup MW, Spearman CW, Taylor BE, Thomas DL, Waked I, Ward JW, Wiktor SZ; Lancet Gastroenterology & Hepatology Commissioners. Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission. Lancet Gastroenterol Hepatol. 2019;4:135-184. [PMID: 30647010 DOI: 10.1016/s2468-1253(18)30270-x] [Cited by in Crossref: 180] [Cited by in F6Publishing: 79] [Article Influence: 90.0] [Reference Citation Analysis]
15 Kondili LA, Robbins S, Blach S, Gamkrelidze I, Zignego AL, Brunetto MR, Raimondo G, Taliani G, Iannone A, Russo FP, Santantonio TA, Zuin M, Chessa L, Blanc P, Puoti M, Vinci M, Erne EM, Strazzabosco M, Massari M, Lampertico P, Rumi MG, Federico A, Orlandini A, Ciancio A, Borgia G, Andreone P, Caporaso N, Persico M, Ieluzzi D, Madonia S, Gori A, Gasbarrini A, Coppola C, Brancaccio G, Andriulli A, Quaranta MG, Montilla S, Razavi H, Melazzini M, Vella S, Craxì A; PITER Collaborating Group. Forecasting Hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals? Liver Int 2018;38:2190-8. [PMID: 29900654 DOI: 10.1111/liv.13901] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
16 Rodríguez de Lope C, Reig M, Matilla A, Ferrer MT, Dueñas E, Mínguez B, F Castroagudín J, Ortiz I, Pascual S, Lledó JL, Gallego A, Arenas JI, Aracil C, Forne M, Muñoz C, Pons F, Sala M, Iñarrairaegui M, Martin-Llahi M, Andreu V, Garre C, Rendón P, Fuentes J, Crespo J, Rodríguez M, Bruix J, Varela M; en representación del Grupo de Estudio de Cáncer Hepático (GECH). Clinical characteristics of hepatocellular carcinoma in Spain. Comparison with the 2008-2009 period and analysis of the causes of diagnosis out of screening programs. Analysis of 686 cases in 73 centers. Med Clin (Barc) 2017;149:61-71. [PMID: 28279536 DOI: 10.1016/j.medcli.2016.12.048] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
17 North F, Tulledge-Scheitel SM, Matulis JC, Pecina JL, Franqueira AM, Johnson SS, Chaudhry R. Population health challenges in primary care: What are the unfinished tasks and who should do them? SAGE Open Med 2018;6:2050312118800209. [PMID: 30245819 DOI: 10.1177/2050312118800209] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Kondili LA, Gamkrelidze I, Blach S, Marcellusi A, Galli M, Petta S, Puoti M, Vella S, Razavi H, Craxi A, Mennini FS; PITER collaborating group. Optimization of hepatitis C virus screening strategies by birth cohort in Italy. Liver Int 2020;40:1545-55. [PMID: 32078234 DOI: 10.1111/liv.14408] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
19 Byers T, Wender RC, Jemal A, Baskies AM, Ward EE, Brawley OW. The American Cancer Society challenge goal to reduce US cancer mortality by 50% between 1990 and 2015: Results and reflections. CA Cancer J Clin 2016;66:359-69. [PMID: 27175568 DOI: 10.3322/caac.21348] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 9.2] [Reference Citation Analysis]